24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Normal variation, population genetics, genetic epidemiology<br />

posed to tobacco smoke (mother smoked actively) .<br />

For the exposure scenario “mother smokes during the first trimester <strong>of</strong><br />

pregnancy”, the OR for AE within the first years <strong>of</strong> the children’s life are<br />

statistically significant (at the age <strong>of</strong> 1 year: OR . [95%CI: 1 .0-41];<br />

1 1 / 2 : OR . [95%CI: 2 .0-43 .9]; 2: OR . [95%CI: 1 .2-24 .6] as well as<br />

6 years: OR . [95%CI: 0 .8-15 .5], adjusted to gender, positive family<br />

history <strong>of</strong> atopy, vaccination and infections and refurbishing during<br />

pregnancy) . Children without tobacco smoke exposure show no association<br />

between the genotype combination and a higher risk for AE .<br />

Additionally, “smoking after pregnancy” could confirm the previously<br />

association, but only by a trend due to the small subgroup .<br />

These associations show a putative role <strong>of</strong> the gene-environment-interactions<br />

in the manifestation <strong>of</strong> AE. However, an identification <strong>of</strong> a<br />

closer time-frame <strong>of</strong> risk toward the exposure “mother smokes” is not<br />

yet possible .<br />

P07.013<br />

Prevalence <strong>of</strong> mutations in the OTOF, PJVK and DDP genes in<br />

subjects with auditory neuropathy<br />

M. Rodríguez-Ballesteros 1,2 , L. A. Aguirre 1,2 , H. del Águila 1 , R. Reynoso 3 , C.<br />

Morera 4 , R. Santarelli 5 , E. Arslan 5 , C. Curet 3 , C. Völter 6 , C. Vincent 7 , E. Gómez-<br />

Rosas 1,2 , M. Villamar 1,2 , M. A. Moreno-Pelayo 1,2 , J. Moreno-Barral 3 , F. Moreno 1,2 ,<br />

I. del Castillo 1,2 ;<br />

1 Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid, Spain, 2 Centro<br />

de Investigación Biomédica en Red de Enfermedades Raras (CIBERER),<br />

ISCIII, Madrid, Spain, 3 Facultad de Ciencias Médicas, Univ. Nacional de Córdoba,<br />

Córdoba, Argentina, 4 Servicio de ORL, Hospital Universitario La Fe, Valencia,<br />

Spain, 5 Department <strong>of</strong> Medical and Surgical Specialities, Audiology and<br />

Phoniatric Service, Univ. <strong>of</strong> Padova, Padua, Italy, 6 ENT Department, University<br />

<strong>of</strong> Würzburg, Würzburg, Germany, 7 Department <strong>of</strong> Otology and Otoneurosurgery,<br />

Centre Hospitalier Universitaire, Lille, France.<br />

Auditory neuropathy (AN) encompasses a variety <strong>of</strong> disorders characterized<br />

by normal otoacoustic emissions (OAE) and absent or grossly<br />

abnormal auditory brainstem responses (ABR) in the affected subjects<br />

. AN can result from environmental or genetic causes . It can be<br />

part <strong>of</strong> a systemic neurodegenerative disorder or it can be an isolated<br />

clinical entity . The primary lesion in AN can be located in the inner hair<br />

cells, in the auditory nerve, or in the synapse in between . In the last<br />

few years, several genes have been shown to be involved in AN . We<br />

have investigated the prevalence <strong>of</strong> mutations in the genes encoding<br />

ot<strong>of</strong>erlin, pejvakin and TIMM8a (OTOF, DFNB59 and DDP1, respectively)<br />

in subjects with isolated auditory neuropathy . A cohort <strong>of</strong> 36 unrelated<br />

subjects with isolated auditory neuropathy were screened for<br />

mutations in these genes by DNA sequencing <strong>of</strong> all exons and flanking<br />

intronic sequences . In 25 subjects (69%), we found two mutant alleles<br />

<strong>of</strong> OTOF, two <strong>of</strong> the mutations being novel . In one subject (2 .8%), we<br />

found a novel mutation in the DDP1 gene . Mutations in this gene are<br />

responsible for Mohr-Tranebjaerg syndrome, an X-linked condition associating<br />

deafness and muscular dystonia . The affected child did not<br />

present with dystonia at the age at which the study was performed .<br />

No mutations were found in the DFNB59 gene . Our results show that<br />

mutations in the OTOF gene are a major cause <strong>of</strong> inherited auditory<br />

neuropathy and suggest that cohorts <strong>of</strong> apparently isolated auditory<br />

neuropathy may contain additional cases <strong>of</strong> the rare Mohr-Tranebjaerg<br />

syndrome .<br />

P07.014<br />

Specific genetic diagnoses in Autism Spectrum Disorders. A 10year<br />

genetic study <strong>of</strong> 159 patients from 5 psychiatric outpatient<br />

care units<br />

S. Lapuyade 1 , M. Assouline 1 , S. Martin 1 , J. Malen 2 , G. Rolland-Manuel 3 , A.<br />

Terkmani 4 , J. Lena 5 , J. Amiel 5 , J. Bonnefont 5 , L. Colleaux 5 , V. Cormier-Daire 5 ,<br />

M. De Blois 5 , S. Lyonnet 5 , V. Malan 5 , A. Philippe 5 , O. Raoul 5 , M. Rio 5 , A. Munnich<br />

5 , S. Whalen 5 ;<br />

1 Hôpital de Jour Santos Dumont, Paris, France, 2 Hôpital de Jour Sésame Autisme,<br />

Chevilly-La-Rue, France, 3 Hôpital de Jour d’Antony, Antony, France, 4 IME<br />

Alternat, Antony, France, 5 Département de génétique, Hôpital Necker Enfants<br />

Malades, Paris, France.<br />

Since 1998, a collaborative study has been undertaken between the<br />

genetic department <strong>of</strong> Necker Enfants Malades hospital and 5 psychiatric<br />

outpatient care units <strong>of</strong> Île-de-France region . From 1998 to <strong>2008</strong>,<br />

159 patients with autistic spectrum disorders (ASDs) have undergone<br />

on-site genetic consultation gathering the following data: family and<br />

personal medical history, detailed psychiatric evaluation, dysmorphological<br />

and neurological clinical examination . Blood and/or urine samples<br />

were collected for genetic testing each time a specific disorder<br />

was suggested after the first consultation, or for systematic screening<br />

<strong>of</strong> common ASD-related disorders . Systematic screening comprised<br />

high resolution banding karyotype, with 22q13 and 15q11q13<br />

FISH analyses, FMR1 gene triplet expansion testing, and metabolic<br />

screening (blood aminoacid and urine organic acid chromatographies,<br />

AICAR, urinary creatin and guanidinoacetate, N-glycosylation, lactate,<br />

pyruvate, ammonium). CGH-array analysis was undertaken in 6% <strong>of</strong><br />

patients thus far . Most <strong>of</strong> the 159 ASD patients (50 females and 106<br />

males) had associated mental retardation ranging from mild to pr<strong>of</strong>ound<br />

.<br />

21 specific diagnoses were obtained for 30 patients: fragile X (8 patients),<br />

15q11q13 duplication (2 patients), 22qter deletion, 22q11 .2 deletion,<br />

1p36 deletion, Williams syndrome, trisomy X, Turner syndrome,<br />

interstitial 19q deletion, mosaic ring 15, 8q23q24 duplication, 17p11 .2<br />

duplication, 1q31 duplication, 1q21 duplication, AP1S2 mutation,<br />

Prader-Willi, Cornelia de Lange, CHARGE and Rubinstein-Taybi syndromes,<br />

creatin transporter deficiency (2 patients), GAMT deficiency,<br />

phenylketonuria, and histidinaemia . We present a cohort <strong>of</strong> 159 patients<br />

with ASD. 23 specific genetic disorders were found in 32 patients<br />

(20,1 %) . These results emphasize the importance <strong>of</strong> on site evaluation<br />

<strong>of</strong> these patients .<br />

P07.015<br />

Analysis <strong>of</strong> AcE and At1R gene polymorphisms in Balkan<br />

Endemic Nephropathy<br />

Z. Krcunovic 1 , I. Novakovic 1 , N. Maksimovic 1 , D. Bukvic 2 , S. Simic-Ogrizovic 3 ,<br />

L. Djukanovic 3 , S. Jankovic 4 ;<br />

1 Institute <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>, School <strong>of</strong> Medicine, Belgrade, Serbia, 2 Institute <strong>of</strong><br />

Endemic Nephropathy, Lazarevac, Serbia, 3 Institute <strong>of</strong> Nephrology and Urology,<br />

Belgrade, Serbia, 4 Institute <strong>of</strong> Epidemiology, Belgrade, Serbia.<br />

Balkan endemic nephropathy (BEN) is a multifactorial disorder with<br />

still unexplained hereditary component . Similarity <strong>of</strong> BEN and cyclosporine<br />

nephropathy suggests possible common ethiopathogenetic<br />

mechanisms . Considering the role <strong>of</strong> renin-angiotensin system in<br />

emergence <strong>of</strong> cyclosporine nephropathy and other types <strong>of</strong> kidney<br />

disease, candidate genes for association studies in BEN were chosen<br />

. We performed analysis <strong>of</strong> I/D polymorphism in gene encoding for<br />

angiotensin-converting enzyme (ACE) and A1166C polymorphism in<br />

gene encoding for type I receptor for angiotensin II (AT1R) . The study<br />

was carried out in a group <strong>of</strong> 50 patients with BEN diagnosis according<br />

to criteria <strong>of</strong> Danilovic, derived from endemic region in Kolubara district<br />

. Two control groups consisted <strong>of</strong> 50 healthy persons (C) and <strong>of</strong> 45<br />

patients with other nephropathies (NBEN), both matched by age and<br />

gender . DNA for gene analysis was extracted from peripheral blood<br />

leukocytes . For detection <strong>of</strong> ACE I/D and AT1R A1166C gene polymorphisms<br />

PCR and PCR/RFLPS methods were used, respectively . We<br />

found that frequency <strong>of</strong> ACE DD genotype was 41 .66%, 43 .14% and<br />

84 .61% in BEN, C and NBEN group, respectively . For AT1R A1166C<br />

gene polymorphism frequency <strong>of</strong> CC genotype was 10 .41%, 8 .69%<br />

and 5 .72%, respectively . Our results showed no difference in analysed<br />

genotypes between BEN and C group. However, we found significantly<br />

higher frequency <strong>of</strong> ACE DD genotype and lower frequency <strong>of</strong> AT1R<br />

1166 CC genotype in NBEN group . Although these results do not indicate<br />

significant role <strong>of</strong> ACE and AT1R gene polymorphisms in BEN,<br />

we will proceed in investigation <strong>of</strong> other members <strong>of</strong> renin-angiotensin<br />

system .<br />

P07.016<br />

compound heterozygosity between Hbs and b-thalassemia.<br />

implication for the neonatal diagnostic <strong>of</strong> hemoglobinopathies<br />

S. Pissard 1,2 , N. Ellachtar 3 , C. Albert 1 , C. Godart 1 , F. Galacteros 4 , H. Puehringer<br />

5 , C. Oberkanins 5 , H. Wajcman 3 ;<br />

1 laboratory <strong>of</strong> genetics, AP-HP,Hop Henri Mondor, creteil, France, 2 INSERM,<br />

U841 eq 11, Creteil, France, 3 INSERM, U841 eq 11, creteil, France, 4 UMGGR,<br />

AP-HP, Hop Henri mondor, creteil, France, 5 ViennaLab Diagnostics, Vienna,<br />

Austria.<br />

Compound heterozygosity between Hb S and b-thalassemia is a form<br />

<strong>of</strong> sickle cell anemia (SCA) with a clinical severity varying considerably .<br />

The clinical phenotype depend upon the type <strong>of</strong> thalassemic defect but<br />

also on other factors . To clarify the spectrum <strong>of</strong> b-thal associated with

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!